Clinical Trial Update: A Study on How NNC0174-1213 Works in People With Overweight or Obesity. [Phase 1]

View source ↗

Summary

A Phase 1 study of NNC0174-1213 in people with overweight or obesity is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• NNC0174-1213

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity, Overweight | Phase 1 | Status: RECRUITING